ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : endocrine dysfunction
Status : Closed
Field of Research : Basic Pharmacology
Clear All
Filter by Field of Research
Basic Pharmacology (6)
Analytical Biochemistry (1)
Biochemistry and Cell Biology (1)
Cell Physiology (1)
Endocrinology (1)
Medical Physiology (1)
Filter by Socio-Economic Objective
Endocrine organs and diseases (incl. diabetes) (2)
Cardiovascular system and diseases (1)
Men’s health (1)
Reproductive system and disorders (1)
Filter by Funding Provider
National Health and Medical Research Council (4)
Australian Research Council (2)
Filter by Status
Closed (6)
Filter by Scheme
Project Grants (3)
Discovery Projects (1)
Linkage Infrastructure, Equipment and Facilities (1)
Research Fellowships (1)
Filter by Country
Australia (2)
Filter by Australian State/Territory
VIC (2)
NSW (1)
SA (1)
  • Researchers (4)
  • Funded Activities (6)
  • Organisations (12)
  • Funded Activity

    Pharmacological Inhibition Of IRAP As A Novel Antifibrotic Strategy

    Funder
    National Health and Medical Research Council
    Funding Amount
    $1,036,370.00
    Summary
    There are very few treatments that can reduce heart stiffening, called fibrosis, which is seen in patients with high blood pressure or in patients who have had a heart attack. This project will test new drugs that we have developed that act by a unique mechanism to reverse or prevent cardiovascular disease in patients with poorly-functioning hearts and blood vessels.
    More information
    Funded Activity

    Is Overactive Bladder A 'Bladder Itch'? Identification Of Itch Specific Pathways Within The Bladder

    Funder
    National Health and Medical Research Council
    Funding Amount
    $720,585.00
    Summary
    Overactive bladder is a leading cause of nocturia, urgency and incontinence. These symptoms arise from sensory nerve fibres in the bladder. We have identified key irritant mechanisms, including the bile acid receptor TGR5 and Mrgpr family, thought to only exist in the skin, also innervate the bladder. We hypothesis that the clinical entity overactive bladder, is triggered by pathological activation of bladder afferents by such irritants and that overactive bladder is essentially a bladder itch.
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP0557833

    Funder
    Australian Research Council
    Funding Amount
    $220,000.00
    Summary
    Novel sources of nitric oxide (NO) in cells: Implications for an endocrine role for NO. Communication between cells is essential for coordinating and controlling a healthy body. A key regulator and cell-communicating molecule is the gas, nitric oxide. Although nitric oxide is a simple substance we still do not fully understand all aspects of its cellular functions. It is assumed that nitric oxide is synthesised in the body and, after release, is rapidly metabolized and eliminated. Reductions in .... Novel sources of nitric oxide (NO) in cells: Implications for an endocrine role for NO. Communication between cells is essential for coordinating and controlling a healthy body. A key regulator and cell-communicating molecule is the gas, nitric oxide. Although nitric oxide is a simple substance we still do not fully understand all aspects of its cellular functions. It is assumed that nitric oxide is synthesised in the body and, after release, is rapidly metabolized and eliminated. Reductions in the levels of nitric oxide in the body are associated with several diseases states and states of dysfunction including cardiovascular disease, diabetes and also impotence. Professor Triggle's study seeks to characterize how tissues may store nitric oxide, thus prolonging the life of nitric oxide, and how such stores are released.
    Read more Read less
    More information
    Funded Activity

    Research Fellowship: Protection Of Myocardial Function In Health And Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $631,010.00
    Summary
    Heart failure (HF) is a major cause of death in Australia. A/Prof Rebecca Ritchie heads Heart Failure Pharmacology at Baker IDI. Her research focuses on new drug strategies to maintain heart function in response to diabetes & heart attack, common precursors of HF. Many of the treatments discovered from this work are naturally-occurring antioxidants; enhancing their activity will ultimately reduce progression to HF & death in the >3 million Australians affected by these disorders.
    More information
    Funded Activity

    Investigating A Novel Agent To Limit Brain Injury And Post-stroke Complications

    Funder
    National Health and Medical Research Council
    Funding Amount
    $412,429.00
    Summary
    Stroke is a leading cause of morbidity and mortality worldwide, but treatment options remain limited. The goal of this research project will be to examine the potential of new agent to protect the brain against stroke and to also treat complications that typically occur after stroke including infection and weight loss. It is anticipated that this project will ultimately lead to the development of an effective stroke therapy.
    More information
    Funded Activity

    Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0883078

    Funder
    Australian Research Council
    Funding Amount
    $356,000.00
    Summary
    Liquid Chromatography Tandem Mass Spectrometry Steroid Analysis Facility. This first of a new generation of ultra-sensitive analytical mass spectrometers for small molecules will be established as a national assay facility allowing all Australian researchers open access to a new dimension of highly accurate and simultaneous measurements of multiple bodily chemicals such as steroids, vitamins and hormones. It is crucial to developing new knowledge in basic, developmental and pathological cell bio .... Liquid Chromatography Tandem Mass Spectrometry Steroid Analysis Facility. This first of a new generation of ultra-sensitive analytical mass spectrometers for small molecules will be established as a national assay facility allowing all Australian researchers open access to a new dimension of highly accurate and simultaneous measurements of multiple bodily chemicals such as steroids, vitamins and hormones. It is crucial to developing new knowledge in basic, developmental and pathological cell biology and for underpinning commercial developments of new molecular targets for therapeutic drugs for many diseases including cancer, cardiovascular disease and reproductive disorders. This facility is pivotal to maintaining international competitiveness in many areas of biological research in national priority areas.
    Read more Read less
    More information

    Showing 1-6 of 6 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback